Abstract:The ability of C1 to bind to the Fc5mu-fragment of a monoclonal IgM was determined by means of a haemolytic C1-inhibition assay. Fc5mu fragments were produced by trypsin digestion at five different temperatures ranging from 54-62 degrees (2 degrees increments) and were purified by immunoadsorption through a column of monospecific anti-Fabmu and by molecular exclusion chromatography. Analytical ultracentrifugation showed the final preparations to be free of aggregates. A plot of mug Fc5mu required to inhibit 50% of available C1 versus temperatures of production of the fragment yielded a curve with a minimum at 58-60 degrees. Upon mild reduction and alkylation of these Fc5mu fragments their C1-fixing capacity became approximately the same irrespective of temperature of production. Fc5mu was also prepared at 25 degrees in the presence of 5 M urea, purified by immunoadsorption as before and aliquots then exposed to temperatures ranging from 40-70 degrees (5 degrees increments) for 15 min. After aggregates had been removed by chromatography a similar minimum in C1-fixation was again observed at 60 degrees. Reduction and alkylation once more abolished these differences. Fc5mu and its reduced and alkylated subunits, produced at 60 degrees and then exposed to various concentrations of urea (0-7 M) for 24 hd did not yield a minimum in C1 fixation. Reduced and alkylated Fcmu incubated at various temperatures (40-70 degrees) also did not fix C1 differentially. Examination in the near and far u.v. region of the circular dichroism spectra of different Fc5mu preparations showed a gradual loss of structure associated with restricted aromatic chromophores and secondary (beta) structure with increased temperature. Urea denaturation had a more pronounced and irreversible effect on Fc5 mu conformation. These changes could not be correlated with the CU-fixation patterns observed. It would therefore appear that elevated temperatures induce a static change in the pentameric FC-part of IgM which in turn directly influences or modulates the availability of the C1-binding site. The importance of disulphide bonds in maintaining these temperature-induced changes in Fc5mu was also indicated.

Microstructure, Mechanical Properties, in Vitro Degradation and Cytotoxicity of Mg-4zn-3ha Alloy for Biodegradable Implant Materials

Microstructure, Mechanical Properties, in Vitro Degradation and Cytotoxicity Evaluations of Mg–1.5Y–1.2Zn–0.44Zr Alloys for Biodegradable Metallic Implants

Biocompatibility of magnesium-zinc alloy in biodegradable orthopedic implants

Evaluation on the corrosion resistance, antibacterial property and osteogenic activity of biodegradable Mg-Ca and Mg-Ca-Zn-Ag alloys

In Vitro and in Vivo Studies on As-Extruded Mg- 5.25Wt.%zn-0.6Wt.%ca Alloy As Biodegradable Metal

Microstructure, Mechanical Properties, Corrosion Behavior and Biocompatibility of As-Extruded Biodegradable Mg–3Sn–1Zn–0.5Mn Alloy

In Vitro Study on Mg-Sn-Mn Alloy As Biodegradable Metals

Microstructure, Mechanical Properties, and in Vitro Corrosion Behavior of Biodegradable Zn-1Fe-xMg Alloy

Enhanced Mechanical Properties, Corrosion Resistance, Cytocompatibility, Osteogenesis, and Antibacterial Performance of Biodegradable Mg‐2Zn‐0.5Ca‐0.5Sr/Zr Alloys for Bone‐Implant Application

Corrosion behavior, antibacterial properties and in vitro and in vivo biocompatibility of biodegradable Zn-5Cu-xMg alloy for bone-implant applications

Biodegradable Mg–3Zn Alloy/Titanium–Hydroxyapatite Hybrid Composites: Corrosion and Cytotoxicity Evaluation for Orthopedic Implant Applications

Fingolimod: A Novel Immunosuppressant for Multiple Sclerosis

In Vitro Degradation Performance and Biological Response of a Mg–Zn–Zr Alloy

In Vitro and in Vivo Degradation Behavior of Mg–2Sr–Ca and Mg–2Sr–Zn Alloys

Fabrication and Properties of Zn-3Mg-1Ti Alloy as a Potential Biodegradable Implant Material

In vitro and in vivo assessment of the effect of biodegradable magnesium alloys on osteogenesis

The importance of quaternary structure in the expression of the C1-binding site of IgM.

In vivo biodegradation and biological properties of a Mg-Zn-Ca amorphous alloy for bone defect repair

Degradable magnesium-based alloys for biomedical applications: The role of critical alloying elements

In Vitro and in Vivo Studies on Biodegradable Magnesium Alloy

Biocorrosion and Cytotoxicity Studies on Biodegradable Mg-Based Multicomponent Alloys